Activities

NEWS

[2017/9/21]

An interview of Miyazaki director was televised in NHK WORLD program “Medical Frontiers” on September 16.

[2016/05/30]

We made a poster presentation at a meeting of American Association of Immunologists.

[2016/02/26]

Our website was renewed.

[2015/05/18]

We made a presentation at the 12th Asia Congress of Nutrition on May 16.

[2014/09/01]

We made a presentation at the 61st Japanese Society For Food Science And Technology Conference on August 30 (held at the Nakamura Gakuen University).

[2014/05/10]

We updated information on conference presentations.

[2013/12/25]

An interview of Mr. Miyazaki, President (Currently, Director) was televised in a KBS program (Korean Broadcasting Company) “Shoro Byoshi” on December 18.

Scholarly activity

[May 4, 2013]

We made a poster presentation at the 100th Annual General Meeting of American Association of Immunologists (AAI).To view the report and photos,press here.
Title  Protective effects of orally administered fucoidan mix on immunosuppression by an experimental cancer chemotherapy.
By  Yoshiyuki Miyazaki, Chief Researcher, NPO Research Institute of Fucoidan

[May 8, 2012]

We made a poster presentation at a meeting of American Association of Immunologists.To view the reportphotos,press here.
Title  Enhancement of NK cell activity and Th1 immunity in healthy subjects by orally administered fucoidan mix.
By  Yoshiyuki Miyazaki, Chief Researcher, NPO Research Institute of Fucoidan

[October 12, 2010]

We made a presentation at the International Conference of International Society for Nutraceuticals and Functional Foods) (ISNFF).To view report,press here.
Title  Biological functions and anti-cancer effect of fucoidan from brown algae
By  Yoshiyuki Miyazaki, Chief Researcher, NPO Research Institute of Fucoidan

Fucoidan related scientific journals and documents

Today, active research is conducted on fucoidan and various bioactive functions of fucoidan, such as “anti-cancer action,” “cholesterol-lowering action,” “blood-pressure lowering action” and “anti-virus action,” have been revealed.

Back to Top